Cynapsus Therapeutics Inc. — Form D/A
Cynapsus Therapeutics Inc. of TORONTO, A6, a company, filed a Form D amendment with the SEC on 2013-03-27. The offering totals $13.0M, of which $4.1M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2013-03-27
- Form: D/A
- Accession: 0001532079-13-000003
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $13.0M
- Amount sold: $4.1M
- Remaining: $8.9M
- Investors: 5
- Date of first sale: 2013-03-01
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-193385
Issuer
- Name: Cynapsus Therapeutics Inc.
- CIK: 0001532079
- Entity type: Corporation
- Jurisdiction: CANADA (FEDERAL LEVEL)
- Address: 828 RICHMOND STREET WEST, TORONTO, A6, M6J 1C9
- Phone: 416-703-2449
Officers, directors & promoters (23)
| Name | Role | Location |
|---|
| Julia Levy | Director | Auburn, WA |
| Alan D C Torrie | Director | Toronto, A6 |
| Nathan Bryson | Executive Officer | Morristown, NJ |
| Ilan Oren | Director | Morrisville, NC |
| DAVID HILL | Director | Charlotte, NC |
| Andrew Williams | Executive Officer | Huntington Beach, CA |
| Anthony Giovinazzo | Director | Mississauga, A6 |
| Anthony Giovinazzo | Executive Officer | Mississauga, A6 |
| Perry Molinoff | Director | DALLAS, TX |
| Margaret Nan Hutchinson | Director | Toronto, A6 |
| Thierry D Bilbault | Executive Officer | Toronto, A6 |
| Tamar D Howson | Director | Toronto, A6 |
| Ronald Hosking | Director | Toronto, A6 |
| Rochelle D Stenzler | Director | Toronto, A6 |
| Ilan Nan Oren | Director | Toronto, A6 |
| Tomer Gold | Director | Toronto, A6 |
| Perry Nan Molinoff | Director | Toronto, A6 |
| Nan Hutchinson | Director | Toronto, A6 |
| Rochelle D C Stenzler | Director | Toronto, A6 |
| Alan D C Ryley | Director | Toronto, A6 |
| Alan Torrie | Director | TORONTO, A6 |
| Alan Ryley | Director | TORONTO, A6 |
| Rochelle Stenzler | Director | TORONTO, A6 |
Other filings by this issuer (9)
More